Q2 2023 Holdings
Filed 2023-08-14 | 67 holdings | $3.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bionomics Limited(BNOXN) | ADS | 09063M205 | $178.1K | 80,971 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS NEW | M47238122 | $261.5K | 89,853 | 0.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $377.8K | 190,815 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $1.3M | 6,353,645 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $2.4M | 4,996,565 | 0.1% |
| Molecular Partners AG(MOLN) | ADS | 60853G106 | $2.7M | 443,221 | 0.1% |
| Inventiva SA(IVA) | ADS | 46124U107 | $2.8M | 686,040 | 0.1% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $2.9M | 1,149,425 | 0.1% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $3.1M | 1,370,947 | 0.1% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $3.4M | 20,609,863 | 0.1% |
| Elevation Oncology Inc | COM | 28623U101 | $3.5M | 2,312,200 | 0.1% |
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $3.8M | 1,049,999 | 0.1% |
| Rain Oncology Inc | COM | 75082Q105 | $4.2M | 3,526,729 | 0.1% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $4.8M | 2,813,485 | 0.1% |
| Viracta Therapeutics Inc | COM | 92765F108 | $5.1M | 3,614,662 | 0.1% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $5.9M | 4,326,710 | 0.2% |
| Aravive Inc(VSAREUR) | COM | 03890D108 | $6.0M | 4,784,214 | 0.2% |
| NLS Pharmaceutics LTD | SHS | H57830103 | $6.3M | 5,747,126 | 0.2% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $6.9M | 1,178,787 | 0.2% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $7.5M | 2,989,474 | 0.2% |
| Cidara Therapeutics Inc | COM | 171757107 | $7.8M | 6,861,127 | 0.2% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $8.3M | 1,508,416 | 0.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $11.3M | 6,595,801 | 0.3% |
| Calliditas Therapeutics AB | SPONSERED ADS | 13124Q106 | $11.8M | 750,000 | 0.3% |
| Verve Therapeutics Inc | COM | 92539P101 | $12.2M | 650,000 | 0.3% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $12.5M | 1,685,219 | 0.3% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $13.3M | 1,563,963 | 0.4% |
| Jasper Therapeutics Inc | COM | 471871103 | $13.6M | 9,900,000 | 0.4% |
| Sutro Biopharma Inc | COM | 869367102 | $15.6M | 3,347,946 | 0.4% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $16.6M | 9,544,262 | 0.5% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $17.0M | 1,813,633 | 0.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $18.1M | 1,521,948 | 0.5% |
| Ikena Oncology Inc | COM | 45175G108 | $20.8M | 3,169,164 | 0.6% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $21.0M | 4,365,933 | 0.6% |
| AC Immune SA(ACIU) | SHS | H00263105 | $22.0M | 7,428,379 | 0.6% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $22.5M | 6,851,051 | 0.6% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $23.6M | 8,748,629 | 0.7% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $24.0M | 1,810,835 | 0.7% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $34.4M | 3,196,701 | 1.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $34.9M | 3,360,941 | 1.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $35.0M | 1,846,154 | 1.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $37.7M | 8,652,417 | 1.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $39.2M | 3,120,521 | 1.1% |
| Merus N V | COM | N5749R100 | $42.2M | 1,602,420 | 1.2% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $45.8M | 19,995,332 | 1.3% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $46.7M | 2,739,595 | 1.3% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $48.7M | 4,106,945 | 1.4% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $49.8M | 2,143,036 | 1.4% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $50.7M | 5,870,000 | 1.4% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $58.3M | 9,423,215 | 1.6% |